Document:

Amendment No. 1-Registration Rights Agreement

 Exhibit 10.2 
 AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT 
 This Amendment
No. 1 (this “Amendment”) to that certain Registration Rights Agreement, dated as of October 4, 2011 (the “Registration Rights Agreement”), by and among Puma Biotechnology, Inc., a Delaware corporation (the
“Corporation”), Innovative Acquisitions Corp., a Delaware corporation (“IAC”), and the persons listed on Exhibit A attached thereto (the “Investors”), is made and entered into as of
November 18, 2011. Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the Registration Rights Agreement. 
 RECITALS 
 WHEREAS, the Merger, pursuant to which Merger Sub merged with
and into the Corporation, with the Corporation remaining as the surviving corporation and a wholly-owned subsidiary of IAC, was consummated on October 4, 2011; 
 WHEREAS, following the Merger, the Corporation merged with and into IAC, with IAC remaining as the surviving company, and subsequently changed its name to “Puma Biotechnology, Inc.”;

 WHEREAS, pursuant to Section 8(f) of the Registration Rights Agreement, IAC assumed all of the Corporation’s
rights, duties and obligations under the Registration Rights Agreement upon the consummation of the Merger; 
 WHEREAS,
IAC and certain retail and/or institutional investors (each, a “New Investor” and collectively, the “New Investors”) have entered into subscription agreements, dated as of an even date herewith (the
“Subscription Agreements”), pursuant to which IAC has agreed to sell to the New Investors up to an aggregate of 1,333,267 shares of IAC Stock in exchange for approximately $5 million; 

WHEREAS, the Subscription Agreements provide that the Registration Rights Agreement will be amended so that the New Investors may
become parties thereto and the shares of IAC Stock issuable pursuant to the Subscription Agreements constitute Registrable Shares thereunder; 
 WHEREAS, pursuant to Section 8(d) of the Registration Rights Agreement, an amendment of the Registration Rights Agreement requires the written consent of IAC and the Holders of a majority in
number of the then outstanding Registrable Shares; and 
 WHEREAS, IAC and the Holders holding a sufficient number of
Registrable Shares hereby consent to this Amendment. 
 NOW, THEREFORE, in consideration of the foregoing recitals and
mutual promises hereinafter set forth, IAC and the Holders hereby agree as follows: 
 1. Joinder of the New Investors.
Each New Investor shall be made a party to the Registration Rights Agreement by virtue of its execution of the Omnibus Signature Page attached to the Investor’s Subscription Agreement, and shall be considered an “Investor” as defined
therein. 
 2. Registrable Shares. The shares of IAC Stock issuable to each New Investor pursuant to the Subscription
Agreements shall be considered Registrable Shares under the Registration Rights Agreement. 
 3. Counterparts. This
Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which counterpart, when so executed and 

 
delivered, shall be deemed to be an original and all of which counterparts, taken together, shall constitute one and the same agreement. 

4. Headings. The headings in this Amendment are for convenience of reference only and shall not limit or otherwise affect the
meaning hereof. 
 5. Governing Law. This Amendment shall be governed by, and construed in accordance with, the laws of
the State of New York without regard to principles of conflicts of laws. 
 6. Conflict. In the event of any conflict
between the provisions of this Amendment and the provisions of the Registration Rights Agreement, the provisions of this Amendment shall prevail and the provisions of the Registration Rights Agreement shall be deemed modified by this Amendment as
necessary to resolve such conflict. 
 7. Effect of Amendment. Except as expressly amended by this Amendment and/or by
the preceding Section 6, the terms and provisions of the Registration Rights Agreement shall continue in full force and effect. 
 [The remainder of this page is intentionally left blank.] 

  
 2 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first
above written. 
  

			
	PUMA BIOTECHNOLOGY, INC.
		
	By:	 	/s/ Alan H. Auerbach
	Name:	 	Alan H. Auerbach
	Title:	 	President and Chief Executive Officer

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
			
	INVESTOR:
	
	ADAGE CAPITAL PARTNERS, L.P.
		
	By:	 	/s/ D. Lehan
		 	Authorized Signatory
		
		 	D. Lehan
		 	Name Printed
		
		 	Authorized Signatory
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
							
	INVESTOR:
	
	BBT FUND, L.P.
		
	By:	 	BBT Genpar, L.P., general partner
			
		 	By:	 	BBT-FW, Inc., general partner
				
		 		 	By:	 	/s/ William O. Reimann
		 		 		 	William O. Reimann
		 		 		 	Vice President

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
			
	INVESTOR:
	
	FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND
		
	By:	 	/s/ Jeffrey Christian
		 	Authorized Signatory
		
		 	Jeffrey Christian
		 	Name Printed
		
		 	Deputy Treasurer
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
			
	INVESTOR:
	
	FIDELITY SELECT PORTFOLIOS: HEALTH CARE PORTFOLIO
		
	By:	 	/s/ Jeffrey Christian
		 	Authorized Signatory
		
		 	Jeffrey Christian
		 	Name Printed
		
		 	Deputy Treasurer
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
			
	INVESTOR:
	
	FIDELITY SELECT PORTFOLIOS: BIOTECHNOLOGY PORTFOLIO
		
	By:	 	/s/ Jeffrey Christian
		 	Authorized Signatory
		
		 	Jeffrey Christian
		 	Name Printed
		
		 	Deputy Treasurer
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
			
	INVESTOR:
	
	FIDELITY ADVISOR SERIES VII: FIDELITY ADVISOR BIOTECHNOLOGY FUND
		
	By:	 	/s/ Jeffrey Christian
		 	Authorized Signatory
		
		 	Jeffrey Christian
		 	Name Printed
		
		 	Deputy Treasurer
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
			
	INVESTOR:
	
	FIDELITY SELECT PORTFOLIOS: PHARMACEUTICALS PORTFOLIO
		
	By:	 	/s/ Jeffrey Christian
		 	Authorized Signatory
		
		 	Jeffrey Christian
		 	Name Printed
		
		 	Deputy Treasurer
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
							
	INVESTOR:
	
	FORESITE CAPITAL II-A, LLC
		
	By:	 	Foresite Capital II-A Management, LLC,
	its	 	Managing Member
			
		 	By:	 	/s/ James B. Tananbaum
		 		 	James B. Tananbaum
		 		 	Managing Member

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]

 
			
	INVESTOR:
	
	H&Q HEALTHCARE INVESTORS *
		
	By:	 	/s/ Laura Woodward
		 	Authorized Signatory
		
		 	Laura Woodward
		 	Name Printed
		
		 	Treasurer 
		 	Title

  

	*	The name H&Q Healthcare Investors is the designation of the Trustees for the time being under an Amended & Restated Declaration of Trust dated
April 12, 1987, as amended, and all persons dealing with H&Q Healthcare Investors must look solely to the trust property for the enforcement of any claim against H&Q Healthcare Investors, as neither the Trustees, officers nor
shareholders assume any personal liability for the obligations entered into on behalf of H& Q Healthcare Investors. 

  

			
	INVESTOR:
	
	H&Q LIFE SCIENCES INVESTORS *
		
	By:	 	/s/ Laura Woodward
		 	Authorized Signatory
		
		 	Laura Woodward
		 	Name Printed
		
		 	Treasurer 
		 	Title

  

	*	The name H&Q Life Sciences Investors is the designation of the Trustees for the time being under an Amended & Restated Declaration of Trust dated
February 20, 1992, as amended, and all persons dealing with H&Q Life Sciences Investors must look solely to the trust property for the enforcement of any claim against H&Q Life Sciences Investors, as neither the Trustees, officers nor
shareholders assume any personal liability for the obligations entered into on behalf of H&Q Life Sciences Investors. 

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
			
	INVESTOR:
	
	JANUS GLOBAL LIFE SCIENCES FUND, A SERIES OF JANUS INVESTMENT FUND
		
	By:	 	/s/ Andrew Acker
		 	Andrew Acker
		 	Executive Vice President

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
							
	INVESTOR:
	
	PRUDENTIAL SECTOR FUNDS, INC. – PRUDENTIAL HEALTH SCIENCES FUND D/B/A PRUDENTIAL JENNISON HEALTH SCIENCES FUND (THE “FUND”)
		
	By:	 	 Jennison Associates LLC (“Jennison”),
 as sub-advisor to the Fund

			
		 	By:	 	/s/ David Chan
		 		 	David Chan
		 		 	Managing Director of Jennison and Portfolio Manager to the Fund

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
			
	INVESTOR:
	
	LEERINK SWANN CO-INVESTMENT FUND LLC
		
	By:	 	/s/ Donald D. Notman, Jr.
		 	Authorized Signatory
		
		 	Donald D. Notman, Jr. 
		 	Name Printed
		
		 	Managing Director
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
							
	INVESTOR:
	
	ORBIMED PRIVATE INVESTMENTS IV, LP
		
	By:	 	 OrbiMed Capital GP IV LLC,
 its general partner

		
	By:	 	 OrbiMed Advisors LLC,
 its managing member

			
		 	By:	 	/s/ Carl L. Gordon
		 		 	Carl L. Gordon
		 		 	Member

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
			
	INVESTOR:
	
	FOURTH AVENUE CAPITAL PARTNERS LP
		
	By:	 	Its general partner, Fourth Avenue Capital Partners GP LLC
		
	By:	 	/s/ Daniel Gold
		 	Authorized Signatory
		
		 	Daniel Gold
		 	Name Printed
		
		 	Managing Member
		 	Title
		
	By:	 	/s/ Tracy Fu
		 	Authorized Signatory
		
		 	 
		 	Name Printed
		
		 	Managing Member
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
			
	INVESTORS:
	
	T. ROWE PRICE ASSOCIATES, INC.
	Investment Adviser, for an on behalf of the advisory clients listed below (Investors):
	 T. Rowe Price Health Sciences Fund, Inc.

	 T. Rowe Price Health Sciences Portfolio

	 TD Mutual Funds – TD Health Sciences Fund

	 Valic Company I – Health Sciences Fund

	 John Hancock Variable Insurance Trust – Health Sciences Trust

	 John Hancock Funds II – Health Sciences Fund

		
	By:	 	/s/ Kris H. Jenner
		 	Authorized Signatory
		
		 	Kris H. Jenner
		 	Name Printed
		
		 	Vice President
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
			
	INVESTOR:
	
	SALTHILL PARTNERS, L.P.
		
	By:	 	Wellington Management Company, LLP
	As investment adviser
		
	By:	 	/s/ Steven M. Hoffman
		 	Authorized Signatory
		
		 	Steven M. Hoffman
		 	Name Printed
		
		 	Vice President and Counsel
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
			
	INVESTOR:
	
	SALTHILL INVESTORS (BERMUDA), L.P.
		
	By:	 	Wellington Management Company, LLP
	As investment adviser
		
	By:	 	/s/ Steven M. Hoffman
		 	Authorized Signatory
		
		 	Steven M. Hoffman
		 	Name Printed
		
		 	Vice President and Counsel
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
			
	INVESTOR:
	
	HAWKES BAY MASTER INVESTORS (CAYMAN) LP
		
	By:	 	Wellington Management Company, LLP
	As investment adviser
		
	By:	 	/s/ Steven M. Hoffman
		 	Authorized Signatory
		
		 	Steven M. Hoffman
		 	Name Printed
		
		 	Vice President and Counsel
		 	Title

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
	
	INVESTOR:
	
	/s/ Frank Zavrl
	Frank Zavrl

 [Signature Page to Amendment No. 1 to Registration Rights Agreement] 

 
	
	INVESTOR:
	
	/s/ Bryan White
	Bryan White

 [Signature Page to Amendment No. 1 to Registration Rights Agreement]First Amendment to Credit Agreement

 Exhibit 10.1 
 FIRST AMENDMENT TO CREDIT AGREEMENT 
 THIS FIRST AMENDMENT TO CREDIT
AGREEMENT, dated as of November 21, 2011 (this “Amendment”), amends the Credit Agreement dated as of August 24, 2010, among AXIS Capital Holdings Limited (the “AXIS Capital”), certain Subsidiaries of AXIS
Capital party thereto (each a “Designated Subsidiary Borrower” and together with AXIS Capital, the “Borrowers” and each a “Borrower”), each lender from time to time party thereto (collectively, the
“Lenders” and individually, a “Lender”), and Bank of America, N.A., as Administrative Agent, LC Administrator and Fronting Bank (as amended to date, the “Credit Agreement”). Terms defined in the
Credit Agreement are, unless otherwise defined herein or the context otherwise requires, used herein as defined therein. 

WHEREAS, the parties hereto have entered into the Credit Agreement, which provides for the Lenders to extend certain credit facilities to
the Borrower from time to time; 
 WHEREAS, the parties hereto desire to amend the Credit Agreement in certain respects as
hereinafter set forth; and 
 NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration
(the receipt and sufficiency of which are hereby acknowledged), the parties hereto agree as follows: 
 1. AMENDMENTS.
Subject to Section 3 hereof, the Credit Agreement shall be amended, effective as of the date hereof, as follows: 

1.1 Amendments to Section 1.01. Section 1.01 of the Credit Agreement is hereby amended as follows: 

(a) The definition of “Credit Parties” is amended in its entirety to read as follows: 

“Credit Parties” means, collectively, the Borrowers (including any Designated Borrower) and AXIS Finance and
each other Guarantor. 
 (b) The definition of “Investment Guidelines” is amended by deleting the words
“Section 2.13(a)” and inserting “Section 6.01(h)” therefore. 
 (c) The following definitions are inserted in
proper alphabetical order: 
 “AXIS Specialty Holdings” means AXIS Specialty Holdings Bermuda
Limited, a Bermuda company which is a Wholly-Owned Subsidiary directly owned by AXIS Capital. 
 “AXIS
Specialty Holdings Guaranty Date” means the date on which AXIS Specialty Holdings has executed and delivered (a) a Guaranty; (b) a certificate of the secretary or an assistant secretary of AXIS Specialty Holdings, in form and
substance reasonably satisfactory to the Administrative Agent, certifying (i) that attached thereto is a true and complete copy of the Organization Documents of AXIS Specialty Holdings then in effect and as in effect at all times from the date
on which the resolutions referred to in clause (ii) below were adopted to and including the date of such certificate, (ii) that attached thereto is a true and complete copy of resolutions adopted by the board of directors (or similar
governing body) of AXIS Specialty Holdings authorizing the execution and delivery of the Guaranty and the performance of the Guaranty and the other Credit Documents to which it is a party, and (iii) as to the incumbency and genuineness of the
signature of each officer of AXIS Specialty Holdings executing the Guaranty or any of the other Credit Documents; and (c) such legal opinions of counsel to AXIS Specialty Holdings as may be reasonably requested by the Administrative Agent.

 1.2 Amendment to Section 2.03. Section 2.03(a)(ii)(C) of the Credit
Agreement is amended in its entirety to read as follows: 
 “(C) the Borrower requesting such Letter of Credit is an Irish
company, unless the beneficiary of such Letter of Credit is neither habitually resident in Ireland nor has a place of establishment in Ireland.” 
 1.3 Amendments to Section 6.01. Section 6.01of the Credit Agreement is hereby amended as follows: 
 (a) Section 6.01(f) of the Credit Agreement is amended in its entirety to read as follows: 
 “(f) within 15 days after the filing of (i) annual audited GAAP financial statements of AXIS Specialty with the relevant Governmental Authority, a copy of such GAAP financial statements for the
relevant fiscal year, (ii) annual audited GAAP financial statements of AXIS Re, AXIS Specialty Europe and any each other Insurance Subsidiary formed outside the United States with the relevant Governmental Authority, a copy of such GAAP
financial statements for the relevant fiscal year and (iii) Statutory Statements by any other Insurance Company, a copy of such Statutory Statements of such Insurance Company for the relevant fiscal year;” 

(b) Section 6.01(h) of the Credit Agreement is amended by in its entirety to read as follows: 

“promptly after any material amendment or modification of the Investment Guidelines of any Credit Party by the board of directors of
such Credit Party, but in any case not more than once per calendar quarter, a copy of such Investment Guidelines as so amended or modified; and” 
 1.4 Amendments to Section 7.01. Section 7.01(d)(i), (ii), (iii) and (vii) of the Credit Agreement are hereby amended by inserting the words “or , from and after the AXIS
Specialty Holdings Guarantee Date, AXIS Specialty Holdings” immediately following the words “AXIS Specialty”; 

  
 2 

 1.5 Amendment to Section 10.01. Section 10.01(g) of the Credit Agreement is
amended by inserting the following words “or, from and after the AXIS Specialty Holdings Guarantee Date, AXIS Specialty Holdings” immediately following the words “AXIS Finance”. 

2. CONSENT FOR TRANSFER. Subject to Section 3 hereof, notwithstanding anything to the contrary in the Credit Agreement, from
and after the AXIS Specialty Holdings Guarantee Date, AXIS Capital may transfer 100% of the Equity Interests of AXIS Specialty to AXIS Specialty Holdings. 
 3. CONDITIONS PRECEDENT. The Amendments to the Credit Agreement set forth in Section 1 and the Consent in Section 2 shall become effective when each of the conditions
precedent set forth in this Section 3 shall have been satisfied, and notice thereof shall have been given by the Administrative Agent to the Borrower and the Lenders. 

3.1 Receipt of Documents. The Administrative Agent shall have received the following documents: 

(a) this Amendment duly executed by the Borrowers, AXIS Finance, the Administrative Agent and the Required Lenders; and

 (b) all other documents or materials as the Administrative Agent may reasonably request. 

3.2 Compliance with Warranties, No Default, etc. After giving effect to this Amendment, the following statements by each Credit
Party shall be true and correct (and each Credit Party, by its execution of this Amendment, hereby represents and warrants to the Administrative Agent and each Lender that such statements are true and correct as at such times): 

(a) the representations and warranties set forth in Article V of the Credit Agreement and, in the case of AXIS Finance,
Section 21 of its Guaranty, shall be true and correct in all material respects with the same effect as if then made (unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct
in all material respects as of such earlier date); and 
 (b) no Default or Event of Default shall have then
occurred and be continuing. 
 4. REPRESENTATIONS AND WARRANTIES. To induce the Lenders and the Administrative Agent to
enter into this Amendment, each Credit Party represents and warrants to the Administrative Agent and each Lender as follows: 

4.1 Due Authorization, Non-Contravention, etc. The execution, delivery and performance of this Amendment by such Credit Party are
within its powers, have been duly authorized by all necessary action, and do not 
 (a) contravene its
Organization Documents; 

  
 3 

 (b) contravene any contractual restriction, law or governmental regulation
or court decree or order binding on or affecting such Credit Party or any of its Subsidiaries; or 
 (c) result
in, or require the creation or imposition of, any Lien on any of the properties of such Credit Party or any of its Subsidiaries (other than any Liens created by the Loan Documents). 

4.2 Government Approval, Regulation, etc. No authorization or approval or other action by, and no notice to or filing with, any
governmental authority or regulatory body or other Person is required for the due execution, delivery or performance by such Credit Party and its Subsidiaries of this Amendment except such as have been obtained or made and are in full force and
effect. 
 4.3 Validity, etc. This Amendment constitutes the legal, valid and binding obligation of such Credit Party
enforceable against such Credit Party in accordance with its terms except as such enforceability may be limited by (a) bankruptcy, insolvency, reorganization, moratorium, examination or similar laws of general applicability affecting the
enforcement of creditors’ rights and (b) the application of general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

5. MISCELLANEOUS. 
 5.1 Continuing Effectiveness, etc. This Amendment shall be deemed to be an amendment to the Credit Agreement, and the Credit Agreement, as amended hereby, shall remain in full force and effect and
is hereby ratified, approved and confirmed in each and every respect. After the effectiveness of this Amendment in accordance with its terms, all references to the Credit Agreement in the Loan Documents or in any other document, instrument,
agreement or writing shall be deemed to refer to the Credit Agreement as amended hereby. Each other Loan Document is hereby ratified, approved and confirmed in each and every respect by each Credit Party party thereto. 

5.2 Payment of Costs and Expenses. AXIS Capital agrees to pay on demand all reasonable expenses of the Administrative Agent
(including the reasonable fees and out-of-pocket expenses of counsel to the Administrative Agent) in connection with the negotiation, preparation, execution and delivery of this Amendment. 

5.3 Severability. Any provision of this Amendment which is prohibited or unenforceable in any jurisdiction shall, as to such
provision and such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions of this Amendment or affecting the validity or enforceability of such provision in any other
jurisdiction. 
 5.4 Headings. The various headings of this Amendment are inserted for convenience only and shall not
affect the meaning or interpretation of this Amendment or any provisions hereof. 

  
 4 

 5.5 Execution in Counterparts. This Amendment may be executed by the parties hereto
in several counterparts, each of which shall be deemed to be an original and all of which shall constitute together but one and the same agreement. 
 5.6 Governing Law. THIS AMENDMENT SHALL BE DEEMED TO BE A CONTRACT MADE UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW YORK. 

5.7 Successors and Assigns. This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their
respective successors and assigns. 
 [Signature Pages Follow] 

  
 5 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of
the date first above written. 
  

			
	AXIS CAPITAL HOLDINGS LIMITED
		
	By:	 	/s/ Jose Osset
		
	Name:	 	Jose Osset
		
	Title:	 	Sr. Vice President and Treasurer
	
	AXIS SPECIALTY LIMITED
		
	By:	 	/s/ Jose Osset
		
	Name:	 	Jose Osset
		
	Title:	 	Sr. Vice President and Treasurer
	
	AXIS RE LIMITED
		
	By:	 	/s/ Tim Hennessy
		
	Name:	 	Tim Hennessy
		
	Title:	 	Executive Vice President and Director
	
	AXIS SPECIALTY EUROPE LIMITED
		
	By:	 	/s/ Tim Hennessy
		
	Name:	 	Tim Hennessy
		
	Title:	 	Executive Vice President and Director
	
	AXIS SPECIALTY FINANCE LLC
		
	By:	 	/s/ Andrew M. Weissert
		
	Name:	 	Andrew M. Weissert
		
	Title:	 	President and Chief Executive Officer

  

			
	
	AXIS SPECIALTY INSURANCE COMPANY
		
	By:	 	/s/ Andrew M. Weissert
		
	Name:	 	Andrew M. Weissert
		
	Title:	 	Sr. Vice President, General Counsel and Secretary
	
	AXIS INSURANCE COMPANY
		
	By:	 	/s/ Andrew M. Weissert
		
	Name:	 	Andrew M. Weissert
		
	Title:	 	Sr. Vice President, General Counsel and Secretary
	
	AXIS REINSURANCE COMPANY
		
	By:	 	/s/ Andrew M. Weissert
		
	Name:	 	Andrew M. Weissert
		
	Title:	 	Sr. Vice President, General Counsel and Secretary
	
	AXIS SURPLUS INSURANCE COMPANY
		
	By:	 	/s/ Andrew M. Weissert
		
	Name:	 	Andrew M. Weissert
		
	Title:	 	Sr. Vice President, General Counsel and Secretary

  

			
	
	BANK OF AMERICA, N.A., as Administrative Agent, L/C Administrator, Fronting Bank and a Lender
		
	By:	 	/s/ Debra Basler
		
	Name: 	 	Debra Basler
		
	Title:	 	Managing Director

  

			
	DEUTSCHE BANK AG NEW YORK BRANCH
		
	By:	 	/s/ John S. McGill
		
	Name: 	 	John S. McGill
		
	Title:	 	Director
		
	By:	 	/s/ Virginia Cosenza
		
	Name: 	 	Virginia Cosenza
		
	Title:	 	Vice President

  

 
			
	 WELLS FARGO BANK, NATIONAL
 ASSOCIATION

		
	By:	 	/s/ Karen Hanke
		
	Name: 	 	Karen Hanke
		
	Title:	 	Director

  

 
			
	 HSBC BANK USA, NATIONAL
 ASSOCIATION

		
	By:	 	/s/ Jody Feldman
		
	Name: 	 	Jody Feldman
		
	Title:	 	Vice President

  

 
			
	THE BANK OF NEW YORK MELLON
		
	By:	 	/s/ Michael Pensari
		
	Name: 	 	Michael Pensari
		
	Title:	 	Managing Director

  

 
			
	CITIBANK, N.A.
		
	By:	 	 
		
	Name: 	 	
		
	Title:	 	

  

 
			
	GOLDMAN SACHS BANK USA
		
	By:	 	/s/ Rick Canonico
		
	Name: 	 	Rick Canonico
		
	Title:	 	Authorized Signatory

  

 
			
	LLOYDS TSB BANK PLC
		
	By:	 	/s/ Rich Herder
		
	Name: 	 	Rich Herder
		
	Title:	 	Head of Financial Institutions
		
	By:	 	/s/ Candi Obrentz
		
	Name: 	 	Candi Obrentz
		
	Title:	 	Vice President

  

 
			
	 MORGAN STANLEY BANK, NATIONAL
 ASSOCIATION

		
	By:	 	/s/ Harry Comninellis
		
	Name: 	 	Harry Comninellis
		
	Title:	 	Authorized Signatory

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00196-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00196-of-00352.parquet"}]]